Results 241 to 250 of about 7,424,540 (294)
Correction: Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib. [PDF]
Sałek-Zań A +7 more
europepmc +1 more source
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications. [PDF]
McMaster T +12 more
europepmc +1 more source
Investigating the determinants of immunotherapy response in the primary tumour of clear cell renal cell carcinoma (RCC). [PDF]
Tang C +8 more
europepmc +1 more source
Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters. [PDF]
Haddad G +12 more
europepmc +1 more source
Tumor-to-tumor metastasis of breast carcinoma to clear cell renal cell carcinoma: a rare case with a review of the literature. [PDF]
Nakajima N +11 more
europepmc +1 more source

